EUVIMEDEUVIMED entdecken
Crossref

Encapsulation of Fibrinogen With Calcium Carbonate for Hemorrhage Control

Henry T Peng iD, Tristan Bonnici, Christian Kastrup, Andrew Beckett

Military Medicine · 2025

DOI: 10.1093/milmed/usaf297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2025. Verfasst von Henry T Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Defence Research and Development Canada, Toronto Research Centre, Toronto, ON M3K 2C9, Canada. Hauptthemen laut MEDLINE: Warfare, Hemorrhage, Fibrinogen, Calcium Carbonate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Defence Research and Development Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Combat-related hemorrhage remains the leading cause of preventable death, accounting for over 60% of fatalities. Dressings containing thrombin-calcium carbonate (CaCO3) particles combined with protonated tranexamic acid have been shown to reduce blood loss and mortality in severe bleeding cases. The integration of fibrinogen further enhances hemostatic efficacy. This study explores the preparation of fibrinogen-encapsulated CaCO3 particles using three innovative methods and evaluates their hemostatic and self-propelling properties. Materials and Methods Fibrinogen-CaCO3 particles were synthesized via water-oil-water encapsulation, precipitation, and gas diffusion methods. For the encapsulation method, fibrinogen in 20 mM HEPES and 1 M carbonate solution was emulsified with oil, Tween 80, and Span 80, and then added to a calcium chloride (CaCl2) solution, and stirred at 400 rotations per minute (RPM) for 10 min. For the precipitation method, fibrinogen was dissolved in 10 mM HEPES and 0.33 M Na2CO3, then combined with 0.33 M CaCl2, and stirred at 200 RPM for 2 h. Alternately, Na2CO3 was replaced with NaHCO3 or (NH4)2CO3. The gas diffusion method involved dissolving fibrinogen in CaCl2 solution, which was exposed to CO2 and NH3 generated from (NH4)2CO3 for 24 h in a desiccator. To quantify fibrinogen distribution, fluorescein isothiocyanate labeling of fibrinogen was performed before particle preparation. Particles were collected, washed, lyophilized, and characterized using microscopy, rotational thromboelastometry, and video motion tracking.

Results

The method and preparation conditions significantly influenced the properties of fibrinogen-CaCO3 particles. Both precipitation and encapsulation methods produced spherical micrometer-sized particles, while the gas diffusion method resulted in irregular shaped particles. Variations in carbonate sources affected particle yield and size. Fibrinogen inclusion led to larger particles in the encapsulation method. Fluorescent microscopy confirmed the successful encapsulation of fibrinogen in all methods, with precipitation particles showing the strongest hemostatic effect. All fibrinogen-containing particles exhibited self-propulsion capabilities, with encapsulation particles outperforming others in terms of response time and propulsion speed.

Conclusions

This study demonstrates that multiple techniques can be used to effectively produce fibrinogen-encapsulated CaCO3 particles with hemostatic and self-propelling properties. Further optimization of the formulation is planned to enhance these properties for hemorrhage control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfareHemorrhageFibrinogenCalcium CarbonateHemostaticsBandagesThrombinTranexamic AcidDrug CompoundingHumans

Substanzen

FibrinogenCalcium CarbonateHemostaticsThrombinTranexamic Acid

Autor:innen und Institutionen

  • Defence Research and Development Canada, Toronto Research Centre, Toronto, ON M3K 2C9, Canada.
  • Michael Smith Laboratories and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • Versiti Blood Research Institute, Milwaukee, WI 53226, United States.
  • St. Michael's Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada.
  • Royal Canadian Medical Services, Ottawa K1A 0K2, Canada.

ORCID-Profile: Henry T Peng

Förderung

  • Defence Research and Development Canada

Zitieren

APA

Peng, H. T., Bonnici, T., Kastrup, C., & Beckett, A. (2025). Encapsulation of Fibrinogen With Calcium Carbonate for Hemorrhage Control. Military Medicine. https://doi.org/10.1093/milmed/usaf297

Vancouver

Peng HT, Bonnici T, Kastrup C, Beckett A. Encapsulation of Fibrinogen With Calcium Carbonate for Hemorrhage Control. Military Medicine. 2025. doi:10.1093/milmed/usaf297

BibTeX
@article{Peng2025,
  author = {Peng, Henry T and Bonnici, Tristan and Kastrup, Christian and Beckett, Andrew},
  title = {Encapsulation of Fibrinogen With Calcium Carbonate for Hemorrhage Control},
  journal = {Military Medicine},
  year = {2025},
  doi = {10.1093/milmed/usaf297}
}
Kostenlos starten →